Immupharma
shares (LSE:IMM) gapped downwards massively in April 2018, and it has moved
sideways since then.
The ADX
period 14 is at the level 40, showing the seriousness of the ongoing
bearishness in the market. DM- is below DM+, meaning bears really have upper
hands now.
The MACD
default parameters, has its histogram and signal lines below the zero line.
There is a Bearish Confirmation Pattern in the market, and when a breakout does
occur, following the current consolidation, it would most probably be in favor
of bears.
IMM is
supposed to go further and further downwards when a directional movement
returns to the market.
Azeez Mustapha
Market Analyst, Trading Signals Provider and Coach
Trading realities: Trading realities
No comments:
Post a Comment